Flying Fish Partners

Venture Capital and Private Equity Principals

Facts

HQ
Seattle, Washington, US
Sectors
Venture Capital and Private Equity Principals
Founded
2016
Employees
16
Last fund
Flying Fish Fund III, LP · $49.3M · 2024 SEC Form D
Funds raised
3 funds SEC Form D filings
Total capital
$129.7M SEC Form D filings

Recent coverage

Front-page news, podcasts and videos about Flying Fish Partners

See all 82

Accipiter Bio raises $10.5M more to speed AI-designed multi-target protein drugs, expanding clinical pipeline

Seattle biotech Accipiter Bio raised an additional $10.5 million from existing investors to accelerate development of AI-designed multi-target protein therapeutics and expand its team and clinical pipeline. The company, now 22 people strong and partnered with Pfizer and Kite/Gilead, will use the funds to advance three to four programs—focusing mainly on immunology alongside oncology—after emerging from stealth last year with $12.7 million.

Fund History

  1. Flying Fish Fund III, LP 2024 · $49.3M SEC Form D
  2. Flying Fish Fund II, LP 2020 · $52.7M SEC Form D
  3. Flying Fish Fund I, LP 2017 · $27.8M SEC Form D

People

See all 4

Online